CAS: 3875-51-2; Isopropylcyclopentane

该化合物是一种循环碳氢化合物,分子式为C8H16,其特点是环戊烷环,代之以异丙基组;该化合物具有有利的物理化学特性,包括极地低和中度挥发性,因此适合作为溶剂或有机合成中间体的应用;其饱和结构在典型反应条件下具有稳定性;而分支异丙基化合物组则会增强消毒效应,可能影响催化工艺中的选择性;异丙环丙烷也可作为碳氢再活动研究的示范化合物或特殊燃料配制的组成部分;其明确界定的结构可以精确地描述化学系统中的特性和可预测的行为.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号24460-61-5 4-propan-2-ylid... | CAS号2175-91-9 6,6-二甲基富烯 | CAS号108-23-6 氯甲酸异丙酯 | CAS号142-29-0 环戊烯 | CAS号1462-06-2 Cyclopentanemet... | CAS号765-83-3 Isopropylidenec... | CAS号542-92-7 环戊二烯 | CAS号105995-04-8 1-iodo-6-methyl... | CAS号609-26-7 2-甲基-3-乙基戊烷 | CAS号584-94-1 2,3-二甲基己烷 | CAS号95-47-6 邻二甲苯 | CAS号108-38-3 间二甲苯 | CAS号638-04-0 顺-1,3-二甲基环己烷 | CAS号589-90-2 1,4-二甲基环己烷

合成工艺路线路线简述

  • 合成目标产物 Isopropylcyclopentane 主要起始原料 1,3-Cyclopentadiene
  • (文献来源)合成步骤主要原料 1,3-Cyclopentadiene
📜1-异丙基环戊烯置于铂体系中,化学反应生成异丙环戊烷
参考文献:Eisenlohr,Fortschritte Der Chemie,Physik Und Physikalischen Chemie,Vol. 18,# 9,P. 24
标题:Eisenlohr,Fortschritte Der Chemie,Physik Und Physikalischen Chemie,Vol. 18,# 9,P. 24

专利信息


专利号:US-6184168-B1
优先权日:1997-09-22
标题:Synthesis of 1,4-trans-polybutadiene using a lanthanide organic acid salt catalyst
发明人:LYNCH THOMAS J
权利人:BRIDGESTONE CORP
摘要:The invention provides a catalyst composition, comprising: (a) an organolithium compound; and, (b) an organic acid salt of lanthanide series element; wherein: (1) only components (a) and (b) are required to promote the synthesis of 1,4-trans-polybutadiene; (2) the ratio of component (a) to component (b) is selected to maximize formation of the trans structure of said 1,4-trans-polybutadiene; and, (3) components (a) and (b) are selected for enabling further diblock synthesis. The invention further contemplates a process for using the catalyst to synthesize 1,4-trans-polybutadiene and other polymers and copolymers having trans configuration in the conjugated diene monomer contributed units.

专利号:US-2003162992-A1
优先权日:2001-12-14
标 题 :Preparation of intermediates useful in the synthesis of antiviral nucleosides
发明人:WATANABE KYOICHI A; DU JINFA
摘要:The present invention is an efficient process for the manufacture of α-acyloxyacetaldehyde, a key intermediate in the synthesis of 1,3-oxathiolane and 1,3-dioxolane nucleosides.

专利号:US-10905769-B2
优先权日:2015-11-13
标 题:Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
发明人:BURKE JR TERRENCE R; HYMEL DAVID T; TSUJI KOHEI
权利人:THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
摘要:The description provides novel compounds that may serve as anticancer therapeutics. The compounds of the description bind to polo-like kinases through the polo-box domain. The peptide derivatives of the description have achieved improved efficacy in biochemical assays against Plk1. Exemplary compounds of the description include macrocyclic peptidomimetics with high affinity and selectivity for polo-like kinases, which may provide the basis for a new genre of anticancer therapeutics. Other exemplary compounds of the description include bi-valent compounds with that bind to polo-like kinases through both kinase domain and polo-box domain simultaneously by incorporating additional moieties that target Plk1 kinase domain, which significantly enhances affinitity relative and may provide the basis for a new genre of anticancer therapeutics. The description also provides methods of use, methods of preparation, compositions, and kits thereof. Further, the description provides a novel method of design and/or synthesis of phosphoryl-derived peptide derivatives useful as therapeutic agents.

专利号:US-6432933-B1
优先权日:1997-07-07
标 题 :Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
发明人:CARROLL CAROLYN DIIANNI; DOLLE III ROLAND ELLWOOD; SHIMSHOCK YVONNE CLASS; HERPIN TIMOTHEE FELIX
权利人:PHARMACOPEIA INC
摘要:Compounds of Formula I n are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or α-hydroxyamide group and Z is an acyl or α-ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.

专利号:US-7858809-B2
优先权日:2004-04-12
标题 :Process for production of pyrazole-fused ring derivatives
发明人:NEGI SHIGETO; SHIMIZU TOSHIKAZU; KURODA HIROSHI; SHIMOMURA NAOYUKI; SASHO MANABU; HOSHINO YORIHISA; KUBOTO MANABU
权利人:EISAI R&D MAN CO LTD
摘要:Intermediates useful for the synthesis of pyrazole-fused ring derivatives, such as 7-phenylpyrazolo [1,5-a]pyridine derivatives, and method for producing the same. Method for producing compound represented by the general formula (II), wherein Z 1 and Z 2 each independently represents a methine group or a nitrogen atom; R l represents an ethyl group or the like; R 5 represents a hydrogen atom or the like; R 2 and R 3 each independently represents a C 1-6 alkyl group or the like, salts thereof, or solvates of both, comprising the step of: reacting a compound represented by the general formula (I), wherein Z 1 , Z 2 , R 5 , R 1 , R 2 and R 3 each has the same definition as described above, with an organometallic reagent; and then reacting the resulting product with pentafluoroiodobenzene.

专利号:US-2004053999-A1
优先权日:1997-09-17
标题 :Novel compounds and methods for synthesis and therapy
发明人:BISCHOFBERGER NORBERT W; DAHL TERRENCE C; HITCHCOCK MICHAEL J M; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; MILLS ROGER G; WILLIAMS MATTHEW A
摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/978-1-4899-6473-1_6
摘要:Szymanski HA. Cyclopentane Derivatives. 1964. In: Interpreted Infrared Spectra.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知